December 2-3, 2009 - Washington, DC
Impending legislation coupled with new FDA initiatives, leave many companies wondering what to expect as we head into 2010. Biotechnology and Pharmaceutical corporate decision-makers are seeking guidance on what they can do now to protect their business model in the short term and ensure its sustainability in the long term. The BioPharm Regulatory Reform Summit, held in Washington D.C. on December 2nd & 3rd, brings together the FDA, the Biotechnology Industry Organization, the Agency for Healthcare Research and Quality and other senior industry executives to create a strategic action plan for 2010 to effectively respond to healthcare reform and the changing political and economic landscape.
Event Site: http://bit.ly/4EUQd0
Brochure: http://bit.ly/16q73f
Registration: http://bit.ly/2BOKUb
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment